• Results of Bone Marrow Concentrate Intervention for Osteoarthritis of the Hip

    Results of Bone Marrow Concentrate Intervention for Osteoarthritis of the Hip

    I am receiving increased requests for my Outcomes Data following a Bone Marrow Concentrate intervention for osteoarthritis of the hip. There is a paucity of said outcomes data in the scientific literature in part because of the relatively recent introduction of Regenerative Medicine for Osteoarthritis....

    Read More

  • Optimizing Strategies for the Practice of Interventional Orthopedics

    Optimizing Strategies for the Practice of Interventional Orthopedics

    The FDA again held a meeting to address issues pertaining to Regenerative Medicine. At the conclusion of the meeting, an updated set of guidelines was developed for patient protection in the use of stem cells, growth factors, and platelet rich plasma. While still being interpreted by the Regenerative...

    Read More

  • Comparing Stem Cell Outcomes to those of Total Joint Replacements

    Comparing Stem Cell Outcomes to those of Total Joint Replacements

    I recently received the yearly publication from the Orthopedic and Rheumatology Institute of the Cleveland Clinic; the latter recognized as one of the 10 most prestigious orthopedic centers in the nation. Every year the publication, a marketing exercise by the Cleveland Clinic, focuses on certain subspecialty...

    Read More

  • Total hip replacement, what can go wrong

    Introduction and background While the benefits of total hip replacements are numerous, there is a known incidence of associated pain leading to early revision. Have attempts at improving the prosthetic implant, shortened lengths of hospital stay, minimally invasive procedures and metal on metal bearings...

    Read More

  • This Week’s Top Stories

      British Hip Society recommends against use of stemmed, large diameter, metal-on-metal implants in primary total hip replacements. Based on discussions held at its annual meeting, the British Hip Society (BHS) has issued a statement on the use of large diameter metal-on-metal bearing total hip replacements....

    Read More

  • Questions and Answers About Metal-on-Metal Hip Implants

     (From the American Academy of Orthopedic Surgeons Patient Information initiative)  On May 6, 2011, the Food and Drug Administration (FDA) issued a postmarket surveillance studies of total metal-on-metal hip replacement devices. A postmarket surveillance study monitors adverse events after a device...

    Read More

  • Concerns about Metal-on-Metal Hip Implants

    FDA Communication, February 09, 2011 All artificial hip replacement systems have risks related to implant or material wear. Metal-on-metal hip (MoM) replacement systems have unique risks in addition to the general risks of all hip implant systems. In April 2010, the United Kingdom’s (U.K.) Medicines...

    Read More

Back to top